Anaïs Oudin
Latest publications
AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.
- NORLUX Neuro-Oncology Laboratory
- Multiomics Data Science
- Quantitative Biology Unit
- Proteomics of Cellular Signaling
2020 Dec. Nat Commun.11(1):6366.
Glioblastoma organoids: Pre-clinical applications and challenges in the context of immunotherapy.
- NORLUX Neuro-Oncology Laboratory
2020 Dec. Front Oncol.10:604121.
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
- Neuro-Immunology Group
- Computational Biomedicine
- Multiomics Data Science
- Luxembourg Center of Neuropathology
- Personalized Therapy Discovery
2020 Dec. Acta Neuropathol.140(6):919-949. Epub 2020 Oct 3.
Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia.
- Tumor Stroma Interactions
- Platform National Cytometry
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
- Allergy and Clinical Immunology
2018 Apr. Blood.131(14):1617-1621. Epub 2018 Feb 13.
Altered metabolic landscape in IDH-mutant gliomas affects phospholipid, energy, and oxidative stress pathways.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
- Computational Biomedicine
2017 Dec. EMBO Mol Med.9(12):1681-1695.
Regulation of hypoxia-induced autophagy in glioblastoma involves ATG9A.
- NORLUX Neuro-Oncology Laboratory
- Computational Biomedicine
- Platform LUXGEN - Micro-Array
- Tumor Immunotherapy and Microenvironment
2017 Sep. Br J Cancer.117(6):813-825. Epub 2017 Aug 10.
Aptamer functionalization of nanosystems for glioblastoma targeting through the blood-brain barrier.
- NORLUX Neuro-Oncology Laboratory
2017 May. J Med Chem.60(10):4510-4516. Epub 2017 May 10.
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
- Computational Biomedicine
- Platform LUXGEN - Micro-Array
- Platform National Cytometry
2016 May. Oncotarget.7(22):31955-71.
CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
- Cytoskeleton and Cancer Progression
- NORLUX Neuro-Oncology Laboratory
2016 Mar. Oncotarget.7(12):13688-705.
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
2015 Dec. Nat Cell Biol.17(12):1556-68. Epub 2015 Nov 23.
Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Platform LUXGEN - Micro-Array
2015 May. PLoS One.10(5):e0123544.
Glioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.
- NORLUX Neuro-Oncology Laboratory
- Platform National Cytometry
- Platform LUXGEN - Micro-Array
2014 Feb. Acta Neuropathol.127(2):203-1. Epub 2013 Oct 24.
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia.
- Tumor Immunotherapy and Microenvironment
- NORLUX Neuro-Oncology Laboratory
2013 Oct. Proc Natl Acad Sci U S A.110(43):17450-5. Epub 2013 Oct 7.
The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status.
- NORLUX Neuro-Oncology Laboratory
2013 Sep. Neuro Oncol.15(9):1200-11. Epub 2013 May 30.
Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma.
- NORLUX Neuro-Oncology Laboratory
2011 Mar. Proc Natl Acad Sci U S A.108(9):3749-54. Epub 2011 Feb 14.